Basic Information
| LncRNA/CircRNA Name | PSMA3-AS1 |
| Synonyms | NA |
| Region | GRCh38_14:58265365-58298134 |
| Ensemble | ENSG00000257621 |
| Refseq | NR_029434 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | esophageal cancer |
| ICD-0-3 | C15 |
| Methods | RT-qPCR, Western blot |
| Sample | ESCC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | PSMA3-AS1 is significantly up-regulated in ESCC tissues, and the PSMA3-AS1/miR-101/EZH2 axis plays a critical role in ESCC progression. |
| Pubmed ID | 32005028 |
| Year | 2020 |
| Title | Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA |
External Links
| Links for PSMA3-AS1 | GenBank HGNC NONCODE |
| Links for esophageal cancer | OMIM COSMIC |